within Pharmacolibrary.Drugs.C_CardiovascularSystem.C04A_PeripheralVasodilators.C04AX33_Clazosentan;

model Clazosentan
  extends Pharmacolibrary.Drugs.ATC.C.C04AX33;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Clazosentan</td></tr><tr><td>ATC code:</td><td>C04AX33</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Clazosentan is a selective endothelin A (ETA) receptor antagonist developed primarily for the prevention and treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage (aSAH). It acts to inhibit vasoconstriction mediated by endothelin-1, thereby improving cerebral blood flow. Clazosentan is approved for use in some regions such as Japan, but not widely approved globally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from healthy adult subjects after intravenous dosing.</p><h4>References</h4><ol><li><p>van Giersbergen, PL, et al., &amp; Dingemanse, J (2007). Influence of ethnic origin and sex on the pharmacokinetics of clazosentan. <i>Journal of clinical pharmacology</i> 47(11) 1374–1380. DOI:<a href=\"https://doi.org/10.1177/0091270007307337\">10.1177/0091270007307337</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17906281/\">https://pubmed.ncbi.nlm.nih.gov/17906281</a></p></li><li><p>Henrich, A, et al., &amp; Krause, A (2021). PK/PD modeling of a clazosentan thorough QT study with hysteresis in concentration-QT and RR-QT. <i>Journal of pharmacokinetics and pharmacodynamics</i> 48(2) 213–224. DOI:<a href=\"https://doi.org/10.1007/s10928-020-09728-7\">10.1007/s10928-020-09728-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33389549/\">https://pubmed.ncbi.nlm.nih.gov/33389549</a></p></li><li><p>Volz, AK, et al., &amp; Lehr, T (2019). Target-Mediated Population Pharmacokinetic Modeling of Endothelin Receptor Antagonists. <i>Pharmaceutical research</i> 37(1) 2–None. DOI:<a href=\"https://doi.org/10.1007/s11095-019-2723-3\">10.1007/s11095-019-2723-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31823033/\">https://pubmed.ncbi.nlm.nih.gov/31823033</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Clazosentan;
